This Engineer Spent 100 Days Underwater—And It Added 10 Years to His Life, He Claims

Why It Matters

If validated, prolonged hyperbaric exposure could become a non‑pharmaceutical strategy for healthspan extension, reshaping wellness and medical markets. Conversely, premature hype may divert resources from proven lifestyle interventions.

Key Takeaways

• Engineer spent 100 days at 1.6 ATA underwater, reporting health gains
• Reported 7x testosterone rise, 8‑lb weight loss, and lower cholesterol
• Sleep doubled with twice as much REM; EEG showed higher coherence
• Medical experts caution HBOT lacks solid evidence for life‑extension
• XPRIZE trial will enroll 200 subjects in daily multibaric HBOT sessions

Pulse Analysis

Hyperbaric oxygen therapy (HBOT) has long been used for conditions such as decompression sickness and non‑healing wounds, but its broader applications remain a frontier of medical research. Joseph Dituri’s 100‑day underwater stay simulated a continuous 1.6‑atmosphere environment, effectively turning the ocean floor into a living hyperbaric chamber. By maintaining a constant pressure of 25 psi, Dituri could breathe enriched oxygen, a setup that mirrors commercial HBOT units but extends exposure from minutes to months, offering a rare glimpse into long‑term physiological adaptation.

Dituri’s self‑reported metrics are striking: an eight‑pound weight loss, a 72‑point cholesterol drop, a seven‑fold surge in testosterone, and a two‑fold increase in REM sleep accompanied by higher EEG coherence. These changes align with known short‑term effects of HBOT, such as improved oxygen delivery and stem‑cell mobilization, yet the magnitude—especially the testosterone spike—raises questions about measurement accuracy and individual variability. Critics, including diving physiologists and FDA‑qualified clinicians, stress that anecdotal evidence does not equate to proven life‑extension benefits, and that the therapy’s high cost may outweigh unverified gains.

The controversy has spurred a more rigorous scientific response. Dituri has joined Arizona State University’s health‑span team, which is competing for a $101 million XPRIZE to extend healthy human life by 20 years. The upcoming trial will expose 200 volunteers to daily 45‑minute sessions in a multibaric chamber that can mimic pressures from mountain peaks to ocean depths. If the study demonstrates reproducible health markers, it could legitimize HBOT as a mainstream anti‑aging tool, prompting insurers and wellness providers to reconsider coverage and pricing models. Until then, the medical community urges patients to prioritize evidence‑based lifestyle factors—nutrition, exercise, sleep, and social connection—over experimental hyperbaric regimens.